Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NYSE - Delayed Quote USD

ResMed Inc. (RMD)

Compare
219.94
-2.68
(-1.20%)
At close: March 28 at 4:00:02 PM EDT
219.51
-0.43
(-0.20%)
After hours: March 28 at 6:00:11 PM EDT

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Michael J. Farrell BE, MBA, SM CEO & Chairman 2.92M 7.26M 1972
Dr. Peter C. Farrell A.M., B.E., BE (Hons), Ph.D., ScD Founder, Chair Emeritus & Director 459.72k -- 1942
Mr. Brett A. Sandercock Chief Financial Officer 933.66k 1.32M 1967
Mr. Michael J. Rider Chief Legal Officer & Secretary 854.32k -- 1958
Mr. Justin Leong Chief Product Officer 1.2M -- 1977
Mr. Kaushik Ghoshal Chief Commercial Officer - SaaS 1.23M -- 1969
Mr. Alastair Robertson Chief Information Officer -- -- --
Mr. Jim Ellis Chief Compliance Officer -- -- --
Ms. Yvonne-Katrin Pucknat Chief Marketing Officer -- -- --
Ms. Vered Keisar Chief People Officer -- -- --

ResMed Inc.

9001 Spectrum Center Boulevard
San Diego, CA 92123
United States
858-836-5000 https://www.resmed.com
Sector: 
Healthcare

Description

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Corporate Governance

ResMed Inc.’s ISS Governance QualityScore as of March 1, 2025 is 4. The pillar scores are Audit: 4; Board: 9; Shareholder Rights: 3; Compensation: 4.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

April 23, 2025 at 10:59 AM UTC - April 28, 2025 at 12:00 PM UTC

ResMed Inc. Earnings Date

Recent Events

March 20, 2025 at 12:00 AM UTC

Dividend Date

February 13, 2025 at 12:00 AM UTC

Ex-Dividend Date

January 31, 2025 at 12:00 AM UTC

10-Q: Periodic Financial Reports

January 30, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 21, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

October 25, 2024 at 12:00 AM UTC

DEFA14A: Proxy Statements

October 24, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

October 3, 2024 at 12:00 AM UTC

DEFA14A: Proxy Statements

August 16, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 9, 2024 at 12:00 AM UTC

10-K: Periodic Financial Reports

Related Tickers